カテゴリ： MarketLine, アメリカ, 企業調査

Berkshire Hathaway Inc：企業の戦略・SWOT・財務分析

◆英語タイトル：Berkshire Hathaway Inc - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY5154
◆発行会社（調査会社）：MarketLine
◆発行日：2020年3月
◆ページ数：63
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：Financial Services
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Berkshire Hathaway Inc – Strategy, SWOT and Corporate Finance Report
Summary

Berkshire Hathaway Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Berkshire Hathaway Inc (Berkshire) is a diversified holding group. The group, through its subsidiaries, focuses on insurance and reinsurance, freight rail transportation and utility and energy generation and distribution business. It offers property and casualty insurance and reinsurance, and life, health and accident reinsurance products. The group operates railroad systems in North America, which serve the Midwest, Southwestern, Western, Pacific Northwest, and Southeastern ports and regions of the US. Berkshire also focuses on manufacturing, service and retailing, finance and financial products activities. The group primarily operates in the US, Western Europe and Asia Pacific region. Berkshire is headquartered in Omaha, Nebraska, the US.

The group reported direct premiums written of US$45,624 million for the fiscal year ended December 2018 (FY2018), an increase of 13.4% over that in FY2017. Its net premiums written were US$59,216 million in FY2018, a decrease of 4.9% over that in FY2017.

Scope

- Detailed information on Berkshire Hathaway Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Berkshire Hathaway Inc in the form of a SWOT analysis
- An in-depth view of the business model of Berkshire Hathaway Inc including a breakdown and examination of key business segments
- Intelligence on Berkshire Hathaway Inc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Berkshire Hathaway Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Berkshire Hathaway Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Berkshire Hathaway Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Berkshire Hathaway Inc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Berkshire Hathaway Inc: Company Overview
Berkshire Hathaway Inc: Overview and Key Facts
Berkshire Hathaway Inc: Overview
Berkshire Hathaway Inc: Key Facts
Berkshire Hathaway Inc: Key Employees
Berkshire Hathaway Inc: Key Employee Biographies
Berkshire Hathaway Inc: Major Products and Services
Berkshire Hathaway Inc: Company History
Berkshire Hathaway Inc: Management Statement
Berkshire Hathaway Inc: Locations and Subsidiaries
Berkshire Hathaway Inc: Key Competitors
Berkshire Hathaway Inc: Company Analysis
Berkshire Hathaway Inc: Business Description
Berkshire Hathaway Inc: SWOT Analysis
Berkshire Hathaway Inc: SWOT Overview
Berkshire Hathaway Inc: Strengths
Berkshire Hathaway Inc: Weaknesses
Berkshire Hathaway Inc: Opportunities
Berkshire Hathaway Inc: Threats
Berkshire Hathaway Inc: Corporate Financial Deals Activity
Berkshire Hathaway Inc: Financial Deals Overview
Berkshire Hathaway Inc: Targets and Partners
Berkshire Hathaway Inc: Top Deals 2016 – 2020YTD*
Berkshire Hathaway Inc: Advisors
Berkshire Hathaway Inc: Top Legal Advisors
Berkshire Hathaway Inc: Top Financial Advisors
Berkshire Hathaway Inc: Mergers and Acquisitions
Berkshire Hathaway Inc: Corporate Venturing
Berkshire Hathaway Inc: Capital Raising
Berkshire Hathaway Inc: Divestments
Berkshire Hathaway Inc: Private Equity and Ownership
Berkshire Hathaway Inc: Recent Developments
Berkshire Hathaway Inc: News and Events Summary
Berkshire Hathaway Inc: Business Expansion
Berkshire Hathaway Inc: Contracts
Berkshire Hathaway Inc: Corporate Governance
Berkshire Hathaway Inc: Financial Deals
Berkshire Hathaway Inc: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Berkshire Hathaway Inc: Key Facts
Table 2: Berkshire Hathaway Inc: Key Employees
Table 3: Berkshire Hathaway Inc: Company History
Table 4: Berkshire Hathaway Inc: Locations and Subsidiaries
Table 5: Berkshire Hathaway Inc: Key Competitors
Table 6: Berkshire Hathaway Inc: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Berkshire Hathaway Inc: M&A Activity by Geography (TTM*)
Table 8: Berkshire Hathaway Inc: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 9: Berkshire Hathaway Inc: M&A Average Deal Size - Value (US$m)
Table 10: Berkshire Hathaway Inc: Targets and Partners
Table 11: Berkshire Hathaway Inc: Top Deals 2016 - 2020YTD*
Table 12: Berkshire Hathaway Inc: Legal Advisor Ranking by Value (US$m)
Table 13: Berkshire Hathaway Inc: Financial Advisor Ranking by Value (US$m)
Table 14: Berkshire Hathaway Inc: M&A Volume and Value Trend (2016 - YTD*2020)
Table 15: Berkshire Hathaway Inc: M&A Activity by Geography (2016 - YTD*2020)
Table 16: Berkshire Hathaway Inc: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 17: Berkshire Hathaway Inc: Corporate Venturing by Geography (2016 - YTD*2020)
Table 18: Berkshire Hathaway Inc: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 19: Berkshire Hathaway Inc: Capital Raising by Deal Type (2016 - YTD*2020)
Table 20: Berkshire Hathaway Inc: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 21: Berkshire Hathaway Inc: Divestments by Geography (2016 - YTD*2020)
Table 22: Berkshire Hathaway Inc: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 23: Berkshire Hathaway Inc: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 24: Berkshire Hathaway Inc: News and Events Summary
Table 25: Berkshire Hathaway Inc: Business Expansion
Table 26: Berkshire Hathaway Inc: Contracts
Table 27: Berkshire Hathaway Inc: Corporate Governance
Table 28: Berkshire Hathaway Inc: Financial Deals
Table 29: Berkshire Hathaway Inc: Strategy and Operations

★海外企業調査レポート[Berkshire Hathaway Inc：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Narodowy Bank Polski：企業の戦略的SWOT分析
    Narodowy Bank Polski - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • AnaBios Corp：製薬・医療：M&Aディール及び事業提携情報
    Summary AnaBios Corp (AnaBios) is a pre-clinical stage contract research organization that offers drug efficacy studies on human samples. The organization’s products portfolio includes human dorsal root ganglia neuron cultures, human cardiac mesenchymal stem cells, human heart tissue samples, human …
  • Landec Corp (LNDC)：企業の財務・戦略的SWOT分析
    Summary Landec Corp (Landec) is a diversified health solution service provider. The company offers offers food and biomaterial solutions. It develops and markets innovative and proprietary based products for healthy living. The company offers various technologies such as application development and …
  • Mamee-Double Decker (M) Berhad：企業の戦略的SWOT分析
    Mamee-Double Decker (M) Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Cyprotex Ltd-医療機器分野：企業M&A・提携分析
    Summary Cyprotex Ltd (Cyprotex), a subsidiary of Evotec AG is a provider of ADME-Tox contract research services. It provides these services to the biotechnology, pharmaceutical, cosmetics/personal care and chemical industries. The company’s core capabilities include high quality mechanistic toxicolo …
  • Haitong Securities Co., Ltd.：企業の戦略・SWOT・財務分析
    Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Heartland Financial USA, Inc.：企業のM&A・事業提携・投資動向
    Heartland Financial USA, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Heartland Financial USA, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • National Beverage Corp. (FIZZ)：企業の財務・戦略的SWOT分析
    National Beverage Corp. (FIZZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Severoceske doly as：企業の戦略・SWOT・財務情報
    Severoceske doly as - Strategy, SWOT and Corporate Finance Report Summary Severoceske doly as - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • AMEWAS, Inc.：企業の戦略・SWOT・財務情報
    AMEWAS, Inc. - Strategy, SWOT and Corporate Finance Report Summary AMEWAS, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Wynn Macau Ltd：企業の戦略・SWOT・財務情報
    Wynn Macau Ltd - Strategy, SWOT and Corporate Finance Report Summary Wynn Macau Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Xtant Medical Holdings Inc (XTNT)：医療機器：M&Aディール及び事業提携情報
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowr …
  • First Solar Inc (FSLR)：電力：M&Aディール及び事業提携情報
    Summary First Solar Inc (First Solar) is a provider of comprehensive photovoltaic (PV) solar systems. It designs, manufactures, and sells PV solar modules. The company produces solar systems using cadmium telluride technology. First Solar also develops, designs, constructs, and sells PV solar power …
  • Dot Foods Inc：企業の戦略的SWOT分析
    Dot Foods Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • IndiPharm Inc-製薬・医療分野：企業M&A・提携分析
    Summary IndiPharm Inc (IndiPharm) is a clinical research organization that provides drug safety services to support clinical research and marketed products. The organization offers CRO services such as preparing and filing regulatory submissions, obtaining required import and export licenses, protoc …
  • Rolta India Ltd (ROLTA)：企業の財務・戦略的SWOT分析
    Rolta India Ltd (ROLTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • SK Kaken Co Ltd (4628)：企業の財務・戦略的SWOT分析
    SK Kaken Co Ltd (4628) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Ivenix Inc-医療機器分野：企業M&A・提携分析
    Summary Ivenix Inc (Ivenix), formerly Fluidnet Corp is a medical technology company that offers infusion therapy solutions. The company offers products such as intravenous drug infusion pump systems and IV smart pump. Its IV smart pump eliminates air from fluid bag and IV lines to reduce number of a …
  • Kimal plc-医療機器分野：企業M&A・提携分析
    Summary Kimal plc (Kimal) is a medical equipment company that develops, manufactures and markets customised procedure packs and vascular access devices. The company’s products include soft tissue biopsy needles, bone marrow biopsy needles, catheter accessories, catheter lock solution, closure device …
  • Ratnamani Metals and Tubes Ltd：企業の戦略・SWOT・財務情報
    Ratnamani Metals and Tubes Ltd - Strategy, SWOT and Corporate Finance Report Summary Ratnamani Metals and Tubes Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆